Gene · 8913
NIH grants1,078
NIH grants whose papers are about the gene, through NIH's grant-paper links.
301 to 320 of 1,078
Download this page as JSON| Grant | Title | CACNA1G papers | Newest fiscal year |
|---|---|---|---|
| R00DK119412 | Mediterranean Diet, Polyphenol-Rich Foods, Gut Microbiota and Type 2 Diabetes | 1 | 2022 |
| R00HL135258 | Uncovering compensatory mechanisms in family members with disease causing mutations of pulmonary hypertension | 1 | 2022 |
| R01AI097302 | CRAC Channel Deficiency in Immunity to Infection | 1 | 2022 |
| R01CA207371 | Metabolomic Strategies for Discovery and Validation of Biomarkers of Colorectal Cancer Recurrence | 1 | 2022 |
| R01DK091336 | Inhibitory mechanisms of PDGFRa+ interstitial cells in gastrointestinal motility | 1 | 2022 |
| R01DK119188 | Role of GDF15 and its receptor in the CNS regulation of food intake and body weight | 1 | 2022 |
| R01DK119667 | Metallothionein 1E as a Central Regulator of Human Pancreatic Beta Cell Function and Survival | 1 | 2022 |
| R01GM085234 | Molecular physiology of TRPML channels | 1 | 2022 |
| R01GM131101 | Phosphoinositide-Binding Proteins as Regulators of Ubiquitination and Wnt Signaling | 1 | 2022 |
| R01HD094381 | Applying Diffusion Basis Spectrum Imaging to Characterize Human Placenta Immuno-response during normal term and preterm pregnancies | 1 | 2022 |
| R01HL106579 | Nucleolin Regulation of miRome by Shear Stress | 1 | 2022 |
| R01HL141086 | Regulation of cardiac power output in health and disease | 1 | 2022 |
| R01HL142520 | Molecular Determinants of Regional Differences in Human Ventricular Repolarization and Remodeling | 1 | 2022 |
| R01HL143065 | Patterning myocardial specification of human pluripotent stem cells | 1 | 2022 |
| R01HL146107 | Transcriptional regulation in the ventricular conduction system | 1 | 2022 |
| R01NS057499 | Store-operated channels in the nervous system | 1 | 2022 |
| R01NS103090 | Pathogenesis of epilepsy in a SCN8A human mutation mouse model | 1 | 2022 |
| R01NS107131 | Fragile X-associated tremor/ataxia syndrome (FXTAS) pathology and anatomy: imaging and clinical correlates | 1 | 2022 |
| R33NS116203 | Primary sensory neuron-targeted block of Cav3.2 for treatment of chronic neuropathic pain | 1 | 2022 |
| T32DK007276 | Methods in Nephrologic Research | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8913/grants?page=16